Annotation under one of the pictures says the core prep lab will be run by ALS, same guys who do the assays... Cap Raise aside, (and forgotten in a few weeks), 2018 can be an exciting year.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
